Tempus AI (NASDAQ:TEM) Downgraded by TD Cowen to “Hold”

TD Cowen lowered shares of Tempus AI (NASDAQ:TEM) from a buy rating to a hold rating in a report released on Tuesday morning, MarketBeat.com reports. The firm currently has $88.00 target price on the stock.

TEM has been the subject of several other research reports. Needham & Company LLC reaffirmed a “buy” rating and set a $70.00 price objective on shares of Tempus AI in a report on Friday, August 8th. HC Wainwright lifted their price objective on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research report on Friday, September 12th. Piper Sandler reissued a “neutral” rating on shares of Tempus AI in a research note on Friday, August 8th. Canaccord Genuity Group initiated coverage on Tempus AI in a report on Monday. They set a “buy” rating and a $110.00 target price on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Seven equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Tempus AI presently has a consensus rating of “Hold” and a consensus target price of $75.85.

Tempus AI Stock Down 3.6%

Shares of NASDAQ TEM opened at $89.10 on Tuesday. Tempus AI has a 52-week low of $31.36 and a 52-week high of $104.32. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54. The business has a fifty day moving average of $83.27 and a two-hundred day moving average of $66.88. The stock has a market cap of $15.48 billion, a PE ratio of -74.87 and a beta of 4.87.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business had revenue of $314.64 million during the quarter, compared to analysts’ expectations of $296.84 million. During the same quarter last year, the company posted ($6.86) EPS. The firm’s revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Tempus AI will post -6.15 earnings per share for the current fiscal year.

Insider Activity at Tempus AI

In other news, COO Ryan Fukushima sold 5,000 shares of the company’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $92.32, for a total transaction of $461,600.00. Following the transaction, the chief operating officer owned 130,000 shares of the company’s stock, valued at $12,001,600. This represents a 3.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the firm’s stock in a transaction dated Thursday, September 25th. The shares were sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the transaction, the chief executive officer owned 9,141,032 shares in the company, valued at approximately $699,837,409.92. This represents a 3.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 933,662 shares of company stock valued at $68,070,993 over the last quarter. 26.27% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently modified their holdings of TEM. Global Retirement Partners LLC increased its holdings in Tempus AI by 29.5% in the third quarter. Global Retirement Partners LLC now owns 733 shares of the company’s stock valued at $59,000 after purchasing an additional 167 shares during the last quarter. First Horizon Advisors Inc. grew its position in shares of Tempus AI by 12.7% during the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company’s stock worth $89,000 after buying an additional 208 shares during the period. China Universal Asset Management Co. Ltd. grew its position in shares of Tempus AI by 0.7% during the 2nd quarter. China Universal Asset Management Co. Ltd. now owns 33,757 shares of the company’s stock worth $2,145,000 after buying an additional 226 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of Tempus AI by 6.1% in the 2nd quarter. PNC Financial Services Group Inc. now owns 5,003 shares of the company’s stock valued at $318,000 after acquiring an additional 287 shares during the last quarter. Finally, Cranbrook Wealth Management LLC acquired a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $25,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.